Clinical Trials

Pyoderma gangrenosum

Displaying 2 studies

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum Scottsdale/Phoenix, AZ

The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG).
A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum Scottsdale/Phoenix, AZ

The study will evaluate the long-term safety of gevokizumab in treating active PG ulcers